This triple combination is used to study the multi-level synergistic regulatory mechanisms of the growth hormone axis. Tesamoreli primarily acts on upstream regulatory signals, Ipamorelin stimulates growth hormone release through selective pathways, while CJC-1295 prolongs the duration of endogenous signaling. By covering distinct regulatory nodes, this triad enables systematic investigation of GH secretion rhythms, feedback control, and endocrine system synergism. This combination holds significant model research value for studies on the growth axis, circadian rhythms, and metabolism.
The peptide will be provided as lyophilized powder to ensure maximum stability.
